Jerzy P. Szaflarski mainly focuses on Epilepsy, Stroke, Psychiatry, Audiology and Anesthesia. All of his Epilepsy and Temporal lobe and Epilepsy in children investigations are sub-components of the entire Epilepsy study. His Stroke research incorporates themes from Physical therapy, Epidemiology, Incidence and Risk factor.
In the field of Psychiatry, his study on Psychogenic disease, Cannabis and Effects of cannabis overlaps with subjects such as Cannabinoid receptor and Endocannabinoid system. His Audiology research includes elements of Aphasia and Brain mapping. His Anesthesia study combines topics from a wide range of disciplines, such as Refractory, Randomized controlled trial, Status epilepticus, Levetiracetam and Prospective cohort study.
His main research concerns Epilepsy, Audiology, Neuroscience, Stroke and Psychiatry. He has researched Epilepsy in several fields, including Anesthesia, Internal medicine, Pediatrics and Cannabidiol. His Audiology research includes themes of Developmental psychology, Cognition, Neuropsychology and Neuroimaging.
His study on Stroke also encompasses disciplines like
His primary areas of investigation include Epilepsy, Cannabidiol, Audiology, Neuroimaging and Internal medicine. Jerzy P. Szaflarski works in the field of Epilepsy, focusing on Brivaracetam in particular. The Treatment resistant epilepsy research Jerzy P. Szaflarski does as part of his general Cannabidiol study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
Jerzy P. Szaflarski has included themes like Insula, Working memory, Fractional anisotropy, Verbal memory and Functional magnetic resonance imaging in his Audiology study. His Neuroimaging research is classified as research in Neuroscience. His biological study spans a wide range of topics, including Stereo eeg and Prospective cohort study.
His primary areas of study are Epilepsy, Cannabidiol, Audiology, Internal medicine and Adverse effect. His Epilepsy study incorporates themes from Expanded access, Cognition, NIH Toolbox, Cognitive test and Functional magnetic resonance imaging. In the subject of general Cannabidiol, his work in Treatment resistant epilepsy is often linked to In patient, thereby combining diverse domains of study.
The concepts of his Audiology study are interwoven with issues in Neuroimaging, Fractional anisotropy, White matter and Psychogenic disease. Neuroimaging is a subfield of Neuroscience that Jerzy P. Szaflarski studies. His work on Dosing as part of general Internal medicine study is frequently linked to Linear correlation, therefore connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Language lateralization in left-handed and ambidextrous people: fMRI data
J. P. Szaflarski;J. R. Binder;E. T. Possing;K. A. McKiernan.
Neurology (2002)
Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study.
Daniel Woo;Laura R. Sauerbeck;Brett M. Kissela;Jane C. Khoury.
Stroke (2002)
Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study.
Brett M. Kissela;Jane Khoury;Dawn Kleindorfer;Daniel Woo.
Diabetes Care (2005)
Stroke in a Biracial Population The Excess Burden of Stroke Among Blacks
Brett Kissela;Alexander Schneider;Dawn Kleindorfer;Jane Khoury.
Stroke (2004)
Cerebral Hypoxia-Ischemia Stimulates Cytokine Gene Expression in Perinatal Rats
Jerzy Szaflarski;Douglas Burtrum;Faye S. Silverstein.
Stroke (1995)
fMRI study of language lateralization in children and adults.
Jerzy P. Szaflarski;Scott K. Holland;Vincent J. Schmithorst;Anna W. Byars.
Human Brain Mapping (2006)
Multicenter Pilot Treatment Trial for Psychogenic Nonepileptic Seizures: A Randomized Clinical Trial
W. Curt LaFrance;W. Curt LaFrance;Grayson L. Baird;Grayson L. Baird;Grayson L. Baird;John J. Barry;Andrew S. Blum.
JAMA Psychiatry (2014)
Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke A Population-Based Study
Dawn Kleindorfer;Brett Kissela;Alex Schneider;Daniel Woo.
Stroke (2004)
New-onset refractory status epilepticus: Etiology, clinical features, and outcome
Nicolas Gaspard;Nicolas Gaspard;Brandon P. Foreman;Vincent Alvarez;Vincent Alvarez;Christian Cabrera Kang.
Neurology (2015)
Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites.
Alexander T. Schneider;Brett Kissela;Daniel Woo;Dawn Kleindorfer.
Stroke (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Medpace (United States)
University of Cincinnati
University of Cincinnati
University of Alabama at Birmingham
Cincinnati Children's Hospital Medical Center
University of Cincinnati
Brown University
University of Arizona
University of Cincinnati Medical Center
University of Alabama at Birmingham
Washington University in St. Louis
George Mason University
Virginia Tech
National University of Singapore
University of California, Los Angeles
Swedish University of Agricultural Sciences
University of Natural Resources and Life Sciences
University of Copenhagen
McMaster University
Aix-Marseille University
Air Improvement Resource, Inc.
University of Rostock
University of Miami
Spaulding Rehabilitation Hospital
University of Helsinki
University of Milan